Now I have enough calibration data. Let me finalize my assessment.

**Round 1 bracket**: 5.5–7.0 (clearly above rejected papers like DeepSSInter at 5.0, COMET at 5.75, but with significant issues preventing it from reaching the 7.0+ accepted papers like "Redefining Bioactivity Prediction")

**Round 2 narrowing**: Comparing against ProteinWorkshop (6.25, Accept) and "Redefining Bioactivity Prediction" (7.0, Accept), the paper under review has stronger algorithmic novelty than ProteinWorkshop but more significant flaws (overclaim, missing ablation) than the 7.0 paper. Score lands around 6.0.

**Comparison with anchors**:
- vs. DeepSSInter (5.0, Reject): Paper under review is clearly better — more novel task, stronger evaluation, much larger improvements
- vs. LLaPA (6.0, Reject): Paper under review has a more novel task formulation and more rigorous prospective evaluation, though both have methodological gaps
- vs. ProteinWorkshop (6.25, Accept): Comparable contribution strength; paper under review has more algorithmic novelty but also more significant claims issues
- vs. "Redefining Bioactivity Prediction" (7.0, Accept): Similar contribution type (task/evaluation redefinition) but paper under review has the overclaim and missing ablation that the 7.0 paper lacks

Final score: **6.0** — solid contribution with genuine novelty and strong results, tempered by a factual overclaim and a missing key ablation that prevents full validation of the core mechanism.

## Summary
This paper introduces PPI candidate ranking as a task distinct from binary PPI classification: given a target protein and its known interactors, rank candidate proteins by likelihood of interaction. The core method uses contact-map predictions from D-SCRIPT and Topsy-Turvy to identify "active" residue regions in known interactors' embeddings, then ranks novel candidates by cosine similarity to these active regions. A re-ranking stage incorporates additional signals (interaction scores, pDockQ, functional annotations, LLM-based text similarity). Evaluation uses a prospective protocol where STRING v11 interactions serve as training anchors and novel interactions appearing in STRING v12 serve as the test set.

## Strengths
- **Genuinely prospective evaluation design**: Using STRING v11→v12 as a temporal split tests whether models can anticipate future discoveries, fundamentally stronger than static retrospective benchmarks (Section 5.1, Table 1).
- **Substantial early-ranking improvements**: For D-SCRIPT backbone, Recall@10 jumps from 1.24% to 26.41% and MRR from 0.034 to 0.169 — practically meaningful gains that would directly reduce experimental screening costs (Table 1, lines 161–192).
- **Novel interpretability-guided retrieval approach**: Using contact-map-derived active residue regions for embedding similarity (Equations 3–5, Figure 1) is a creative use of model internals as a methodological device rather than for explanation, as explicitly articulated in Section 1.
- **Systematic re-ranking analysis**: Table 2 presents a comprehensive pairwise comparison of 10 re-ranking signals, revealing that PubMedBERT is strongest (75.5% improvement over cosine baseline) while pDockQ underperforms (47.2%), providing useful guidance for practitioners.
- **Rigorous anti-leakage protocol**: GroupKFold split by protein identity with all evaluation on v12 interactions disjoint from training eliminates protein-level data leakage (Section 4.2, line 145).
- **Honest limitations discussion**: Section 6 transparently acknowledges the cold-start problem and the distinction between using interpretability methodologically vs. generating explanations.

## Weaknesses

### Fatal
None.

### Major
- **Overstated "two orders of magnitude" claim**: The paper claims "two orders of magnitude" improvement in the abstract (line 25) and conclusion (lines 278–279). Table 1 shows the largest improvement is D-SCRIPT Recall@5 from 0.0071→0.1832 (~26×, approximately 1.4 orders of magnitude). No metric approaches 100×. This factual overstatement appears in the two most visible locations in the paper and must be corrected.
- **Missing key ablation: full-embedding vs. active-region cosine similarity**: The paper's central claim is that contact-map-guided active residue selection drives the ranking improvement. However, there is no ablation comparing full-embedding cosine similarity (without active-region selection) against the proposed active-region approach. Without this, it is impossible to determine whether the contact-map guidance is what matters, or whether simply computing cosine similarity over arbitrary embedding regions would yield similar gains. This is the single experiment most essential to validating the paper's core mechanism.
- **Coverage trade-off unacknowledged**: The proposed method reduces Prediction Coverage relative to the baselines: D-SCRIPT baseline 0.9544 → Our approach 0.9230; Topsy-Turvy baseline 0.9683 → Our approach 0.9506 (Table 1, lines 163, 170, 181, 188). The method concentrates true positives near the top but loses some entirely. This trade-off is not discussed and matters for practical screening where missing true positives is costly.

### Minor
- **No statistical significance or variance reported**: All results in Table 1 are point estimates across proteins with variable numbers of known/novel partners. Confidence intervals or significance tests for key metrics (especially MRR, Recall@5/10) are needed to assess robustness.
- **Re-ranking signals evaluated individually but never combined**: Despite claiming to "analyze complementarities between methods" (contribution bullet 3, line 33), Table 2 only shows pairwise rank-shift comparisons where each signal is tested in isolation. Testing at least one combined configuration (e.g., PubMedBERT + KeyTerm + IS) would directly support the complementarity claim.
- **Table 2 description incomplete**: Line 206 defines † but the ‡ definition is cut off: "and ‡ is reported." This should be completed.
- **Re-ranking limited to top-10 without contextualizing reach**: Re-ranking applies only to top-10 candidates per protein (line 109), but the paper does not report what fraction of true novel partners fall within this window, limiting understanding of the re-ranking module's practical reach.
- **Merged text fragments in Section 4.1**: Line 89 contains interleaved duplicate text: "For each residue of The activation score of residue j in p_k we define its activation score is defined as" — likely a merging artifact from drafting.

### Trivial
- **Likely typo in Table 1**: Topsy-Turvy Prediction Probability Recall@10 = 0.00117 (line 170), which is lower than Recall@5 = 0.0063, inconsistent with monotonically non-decreasing Recall@k. Should likely be 0.0117.

## Nice-to-Haves
- Breakdown of results by number of known partners |KP(p)| to show how performance degrades as the anchor set shrinks — would provide practical guidance on applicability.
- Discussion of approximation methods or optimization strategies for the O(n_c × |I_k| × d) sliding-window similarity (Eq. 3), given reported runtimes of "hundreds of hours" (line 233).
- Analysis of what fraction of true novel partners fall within the top-10 re-ranking window.

## Removed Points
These points are flagged to be removed, treat them with caution.
- Formatting/style nitpicks about editing artifacts — these are presentation issues, not substance.
- The Topsy-Turvy Recall@10 typo could also be a parser artifact rather than a paper error.

## Novel Insights
The paper makes a genuinely novel contribution by reframing PPI prediction as a candidate ranking task with temporal evaluation. The key insight — that model-internal contact-map activations can be repurposed as a ranking mechanism rather than just classification signals — is conceptually distinct from standard PPI prediction. The prospective STRING v11→v12 evaluation protocol also represents a methodological contribution that the broader PPI prediction community could adopt as a more realistic benchmark.

## Suggestions
- Add the full-embedding cosine similarity ablation — this is the highest-leverage improvement for validating the core claim.
- Correct "two orders of magnitude" to "~26×" or "over one order of magnitude" in the abstract and conclusion.
- Add confidence intervals or bootstrapped significance tests to Table 1 metrics.
- Discuss the Prediction Coverage trade-off explicitly in the results or discussion section.
- Test at least one combined re-ranking configuration to validate the complementarity claim.
- Complete the ‡ definition in Table 2 caption (line 206).
- Clean up merged text fragments in Section 4.1 (line 89).

## Score and Decision

**Calibration anchors retrieved across all rounds:**

| Paper | Avg Score | Round | Comparison |
|-------|-----------|-------|------------|
| S2WHlhvFGg (Drug-Target Interaction) | 3.0 | 1 | Weaker — different problem, less novel, weaker evaluation |
| 1S8ndwxMts (Protein Generative Model Evaluation) | 3.0 | 1 | Weaker — metrics analysis paper with no novel method |
| An87ZnPbkT (GNNAS-Dock) | 3.0 | 1 | Weaker — incremental application paper |
| nWO75tVjfp (CompassDock) | 3.0 | 1 | Weaker — tool/analysis paper, limited novelty |
| eh1fL0zw8o (LLaPA) | 6.0 | 1 | Comparable — similar domain, novel model, but unfair comparisons and missing baselines |
| xNDydjYBmC (PPB Affinity) | 4.6 | 1 | Weaker — data integration approach, less novel task |
| wCwz1F8qY8 (DeepSSInter) | 5.0 | 1 | Weaker — incremental over DeepInter, weaker evaluation |
| QfyZ28FpVY (DEL-Ranking) | 4.0 | 1 | Weaker — different domain, less impactful |
| C81bqFCmMf (COMET) | 5.75 | 2 | Weaker — benchmark paper without novel algorithmic contribution |
| opv67PpqLS (DNALONGBENCH) | 5.67 | 2 | Weaker — benchmark paper without novel method |
| 760br3YEtY (PEEP) | 5.60 | 2 | Weaker — enzyme promiscuity, incremental method |
| sTYuRVrdK3 (ProteinWorkshop) | 6.25 | 2 | Similar — both introduce evaluation frameworks; paper under review has stronger algorithmic novelty but more flaws |
| S8gbnkCgxZ (Redefining Bioactivity) | 7.0 | 2 | Stronger — cleaner claims, larger dataset contribution, no overclaiming |
| 8CKgS18uWx (SEPIT) | 6.25 | 2 | Similar contribution level but different focus |
| IxmWIkcKs5 (ΔΔG Predictor) | 6.75 | 2 | Stronger — more complete validation with fewer claims issues |
| hWmwL9gizZ (Immunogenicity Prediction) | 7.0 | 2 | Stronger — novel method + comprehensive dataset + no overclaim |
| ua5MHdsbck (Data Distillation Protein Design) | 7.0 | 2 | Stronger — cleaner methodology, no factual errors |
| wyF5vNIsO7 (TCR Embeddings) | 6.75 | 2 | Stronger — large-scale empirical contribution with fewer flaws |

**Bracket**: Round 1 placed the paper between 5.5 and 7.0. Round 2 narrowed this to approximately 6.0–6.5. The paper is clearly stronger than all rejected anchors below 5.75 (novel task, stronger evaluation, larger improvements) and comparable to ProteinWorkshop at 6.25. However, it falls below the accepted papers at 7.0 due to the factual overclaim ("two orders of magnitude" when max improvement is ~26×) and the missing core ablation. Compared to LLaPA at 6.0, the paper under review has a more novel task formulation and more rigorous prospective evaluation, placing it slightly above. Final score: **6.0**.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>